Metformin Exerts Anti-AR-Negative Prostate Cancer Activity via AMPK/Autophagy Signaling Pathway

0
140
Scientists explored the mechanism involved in metformin-mediated inhibition of AR-negative prostate cancer.
[Cancer Cell International]
Chen, C., Wang, H., Geng, X., Zhang, D., Zhu, Z., Zhang, G., & Hou, J. (2021). Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway. Cancer Cell International, 21(1), 404. https://doi.org/10.1186/s12935-021-02043-2 Cite
Full Article